You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes

Citation Tools

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Petousis S, Navarro B, Margioula-Siarkou C, et al
2022-RA-1047-ESGO Surgical restaging of early-stage endometrial cancer patients with lymphovascular invasion does not significantly impact their survival outcomes
International Journal of Gynecologic Cancer 2022;32:A132.